本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Inhibrx Biosciences

12.35
+0.09000.73%
盘前11.58-0.7700-6.23%04:09 EDT
成交量:8.54万
成交额:105.94万
市值:1.79亿
市盈率:0.11
高:12.80
开:12.35
低:12.23
收:12.26
数据加载中...
2024/05/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/05/30

重要事件披露

Form 8-K - Current report
2024/05/30

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/23

SEC问询函

Form CORRESP - Correspondence
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

SEC问询函

Form CORRESP - Correspondence
2024/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities